196 related articles for article (PubMed ID: 32930517)
1. Opioid analgesic use and its sequelae: Opioid and other substance use disorders.
Rhee TG; Rosenheck RA
Early Interv Psychiatry; 2021 Aug; 15(4):975-982. PubMed ID: 32930517
[TBL] [Abstract][Full Text] [Related]
2. Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration.
Lin LA; Bohnert ASB; Blow FC; Gordon AJ; Ignacio RV; Kim HM; Ilgen MA
Addiction; 2021 Jan; 116(1):96-104. PubMed ID: 32428386
[TBL] [Abstract][Full Text] [Related]
3. Utilization of treatment by Medicaid enrollees with opioid use disorder and co-occurring substance use disorders.
O'Brien P; Henke RM; Schaefer MB; Lin J; Creedon TB
Drug Alcohol Depend; 2020 Dec; 217():108261. PubMed ID: 32979735
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of co-occurring substance use in individuals with opioid use disorder.
Mahoney JJ; Winstanley EL; Lander LR; Berry JH; Marshalek PJ; Haut MW; Marton JL; Kimble WD; Armistead M; Wen S; Cai Y; Hodder SL
Addict Behav; 2021 Mar; 114():106752. PubMed ID: 33348147
[TBL] [Abstract][Full Text] [Related]
5. Association of opioid or other substance use disorders with health care use among patients with suicidal symptoms.
Vekaria V; Patra BG; Xi W; Murphy SM; Avery J; Olfson M; Pathak J
J Subst Use Addict Treat; 2024 Jan; 156():209177. PubMed ID: 37820869
[TBL] [Abstract][Full Text] [Related]
6. Adverse events among adult Medicaid enrollees with opioid use disorder and co-occurring substance use disorders.
O'Brien P; Henke RM; Schaefer MB; Lin J; Creedon TB
Drug Alcohol Depend; 2021 Apr; 221():108555. PubMed ID: 33596496
[TBL] [Abstract][Full Text] [Related]
7. Treatment utilization among persons with opioid use disorder in the United States.
Wu LT; Zhu H; Swartz MS
Drug Alcohol Depend; 2016 Dec; 169():117-127. PubMed ID: 27810654
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of comorbid substance use disorders among people with opioid use disorder: A systematic review & meta-analysis.
Santo T; Gisev N; Campbell G; Colledge-Frisby S; Wilson J; Tran LT; Lynch M; Martino-Burke D; Taylor S; Degenhardt L
Int J Drug Policy; 2024 Jun; 128():104434. PubMed ID: 38677160
[TBL] [Abstract][Full Text] [Related]
9. Trends in Urine Drug Monitoring Among Persons Receiving Long-Term Opioids and Persons with Opioid Use Disorder in the United States.
Sohn M; Talbert JC; Huang Z; Oser C; Freeman PR
Pain Physician; 2021 Mar; 24(2):E249-E256. PubMed ID: 33740362
[TBL] [Abstract][Full Text] [Related]
10. Comparative Effectiveness Associated With Buprenorphine and Naltrexone in Opioid Use Disorder and Cooccurring Polysubstance Use.
Xu KY; Mintz CM; Presnall N; Bierut LJ; Grucza RA
JAMA Netw Open; 2022 May; 5(5):e2211363. PubMed ID: 35536575
[TBL] [Abstract][Full Text] [Related]
11. The phenomics and genetics of addictive and affective comorbidity in opioid use disorder.
Freda PJ; Moore JH; Kranzler HR
Drug Alcohol Depend; 2021 Apr; 221():108602. PubMed ID: 33652377
[TBL] [Abstract][Full Text] [Related]
12. Can the type of subjective response to first opioid exposure predict the risk of opioid use disorder? A scoping review.
Morris CJ; Mills-Huffnagle S; Zgierska AE
Brain Res Bull; 2022 Oct; 188():67-76. PubMed ID: 35901984
[TBL] [Abstract][Full Text] [Related]
13. Neurocognitive, psychiatric, and substance use characteristics in a diverse sample of persons with OUD who are starting methadone or buprenorphine/naloxone in opioid treatment programs.
Scott TM; Arnsten J; Olsen JP; Arias F; Cunningham CO; Rivera Mindt M
Addict Sci Clin Pract; 2021 Oct; 16(1):64. PubMed ID: 34689841
[TBL] [Abstract][Full Text] [Related]
14. Contraceptive initiation after delivery among women with and without opioid use disorders: A retrospective cohort study in a statewide Medicaid population, 2005-2016.
Charron E; Rennert L; Mayo RM; Eichelberger KY; Dickes L; Truong KD
Drug Alcohol Depend; 2021 Mar; 220():108533. PubMed ID: 33513446
[TBL] [Abstract][Full Text] [Related]
15. Age of initiation, psychopathology, and other substance use are associated with time to use disorder diagnosis in persons using opioids nonmedically.
Schepis TS; Hakes JK
Subst Abus; 2017; 38(4):407-413. PubMed ID: 28723266
[TBL] [Abstract][Full Text] [Related]
16. Pregnant women with opioid use disorder and their infants in three state Medicaid programs in 2013-2016.
Clemans-Cope L; Lynch V; Howell E; Hill I; Holla N; Morgan J; Johnson P; Cross-Barnet C; Thompson JA
Drug Alcohol Depend; 2019 Feb; 195():156-163. PubMed ID: 30677745
[TBL] [Abstract][Full Text] [Related]
17. Association of co-occurring opioid or other substance use disorders with increased healthcare utilization in patients with depression.
Vekaria V; Bose B; Murphy SM; Avery J; Alexopoulos G; Pathak J
Transl Psychiatry; 2021 May; 11(1):265. PubMed ID: 33941761
[TBL] [Abstract][Full Text] [Related]
18. Associations of alcohol use disorder, cannabis use disorder, and nicotine dependence with concurrent opioid use disorder in U.S. adults.
Harton MR; Adams ZW; Parker MA
Exp Clin Psychopharmacol; 2023 Dec; 31(6):998-1004. PubMed ID: 37166911
[TBL] [Abstract][Full Text] [Related]
19. Association of Medicaid expansion and 1115 waivers for substance use disorders with hospital provision of opioid use disorder services: a cross sectional study.
Chang JE; Cronin CE; Lindenfeld Z; Pagán JA; Franz B
BMC Health Serv Res; 2023 Jan; 23(1):87. PubMed ID: 36703146
[TBL] [Abstract][Full Text] [Related]
20. Mortality of treatment-seeking men and women with alcohol, opioid or other substance use disorders - A register-based follow-up study.
Pitkänen T; Kaskela T; Levola J
Addict Behav; 2020 Jun; 105():106330. PubMed ID: 32088539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
